Bicycle Therapeutics (BCYC) Receivables - Net (2019 - 2025)
Bicycle Therapeutics (BCYC) has disclosed Receivables - Net for 7 consecutive years, with $136000.0 as the latest value for Q1 2025.
- For the quarter ending Q1 2025, Receivables - Net changed N/A year-over-year to $136000.0, compared with a TTM value of $136000.0 through Mar 2025, changed N/A, and an annual FY2022 reading of $2.0 million, up 104.5% over the prior year.
- Receivables - Net was $136000.0 for Q1 2025 at Bicycle Therapeutics, down from $233000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $50.0 million in Q1 2023 and bottomed at $136000.0 in Q1 2025.
- Average Receivables - Net over 5 years is $12.5 million, with a median of $2.0 million recorded in 2022.
- The sharpest move saw Receivables - Net soared 2073.91% in 2023, then crashed 99.48% in 2024.
- Year by year, Receivables - Net stood at $1.0 million in 2021, then soared by 104.5% to $2.0 million in 2022, then skyrocketed by 2104.89% to $45.1 million in 2023, then plummeted by 99.48% to $233000.0 in 2024, then tumbled by 41.63% to $136000.0 in 2025.
- Business Quant data shows Receivables - Net for BCYC at $136000.0 in Q1 2025, $233000.0 in Q2 2024, and $45.1 million in Q2 2023.